Predictive value of molecular subtypes in premenopausal women with hormone receptor-positive early breast cancer: Results from the ABCSG Trial 5.

CONCLUSION: Determination of molecular subtypes by IHC is an independent prognostic factor for recurrence and death in premenopausal women with early-stage, hormone receptor-positive breast cancer but is not predictive for outcome of adjuvant treatment with tamoxifen/goserelin or CMF.
PMID: 32546648 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - June 15, 2020 Category: Cancer & Oncology Authors: Bago-Horvath Z, Rudas M, Singer CF, Greil R, Balic M, Lax S, Kwasny W, Hulla W, Gnant M, Filipits M Tags: Clin Cancer Res Source Type: research